Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy.

Int J Nanomedicine · 2014 · PMC4122582 · PMID 25114522

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Anti-tumor effect of RPM/siRNA was also determined at the gene level; a highly significant difference was observed in the levels of VEGFR2 mRNA between the tumors of the RPM/siRNA group and the other groups ( Figure 10C ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.